Related references
Note: Only part of the references are listed.Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities
Xiaohong Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret et al.
SCIENTIFIC REPORTS (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich et al.
STEM CELL REVIEWS AND REPORTS (2020)
Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process
Dat Huu Tran et al.
JOURNAL OF ANTIBIOTICS (2019)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Azithromycin Protects against Zika Virus Infection by Upregulating Virus-Induced Type I and III Interferon Responses
Chunfeng Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo
Shinuan Zeng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Role of prophylactic azithromycin to reduce airway inflammation and mortality in a RSV mouse infection model
Ricardo A. Mosquera et al.
PEDIATRIC PULMONOLOGY (2018)
The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms
Petra Zimmermann et al.
FRONTIERS IN IMMUNOLOGY (2018)
ICR suckling mouse model of Zika virus infection for disease modeling and drug validation
Yu-Hsuan Wu et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation
Mandy Menzel et al.
ONCOTARGET (2017)
Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners
Takashi Muramatsu
JOURNAL OF BIOCHEMISTRY (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway
Bojana Mirkovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum
Danny W. Wilson et al.
BMC BIOLOGY (2015)
Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis
Avraham Beigelman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
Phillip L. Molyneaux et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases
Hui Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Effect of azithromycin on Prevotella intermedia lipopolysaccharide-induced production of interleukin-6 in murine macrophages
Eun-Young Choi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Host-microorganism interactions in lung diseases
Benjamin J. Marsland et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
P. Zarogoulidis et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum
Cecile Crosnier et al.
NATURE (2011)
Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants
Zubair H. Aghai et al.
PEDIATRIC RESEARCH (2007)
Roles of CD147 on t lymphocytes activation and MMP-9 secretion in Systemic Lupus Erythematosus
Gina Pistol et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Single-dose azithromycin for the treatment of cholera in adults
Debasish Saha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
YJ Jang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily
A Di Paolo et al.
PHARMACOLOGICAL RESEARCH (2002)
Share Paper
